226 related articles for article (PubMed ID: 2413798)
1. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT
Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
[TBL] [Abstract][Full Text] [Related]
2. Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions.
Itoyama Y; Webster HD; Sternberger NH; Richardson EP; Walker DL; Quarles RH; Padgett BL
Ann Neurol; 1982 Apr; 11(4):396-407. PubMed ID: 6179456
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
[TBL] [Abstract][Full Text] [Related]
4. Measles encephalomyelitis: lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination.
Gendelman HE; Wolinsky JS; Johnson RT; Pressman NJ; Pezeshkpour GH; Boisset GF
Ann Neurol; 1984 Apr; 15(4):353-60. PubMed ID: 6204579
[TBL] [Abstract][Full Text] [Related]
5. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
6. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis.
Möller JR; Yanagisawa K; Brady RO; Tourtellotte WW; Quarles RH
Ann Neurol; 1987 Oct; 22(4):469-74. PubMed ID: 2449119
[TBL] [Abstract][Full Text] [Related]
7. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
Mastronardi FG; Moscarello MA
J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
[TBL] [Abstract][Full Text] [Related]
8. P2, P1, and P0 myelin protein expression in developing rat sixth nerve: a quantitative immunocytochemical study.
Hahn AF; Whitaker JN; Kachar B; Webster HD
J Comp Neurol; 1987 Jun; 260(4):501-12. PubMed ID: 2440915
[TBL] [Abstract][Full Text] [Related]
9. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
10. Human polyomavirus JCV and expression of myelin genes.
Gordon J; Gallia GL; Del Valle L; Amini S; Khalili K
J Neurovirol; 2000 May; 6 Suppl 2():S92-7. PubMed ID: 10871794
[TBL] [Abstract][Full Text] [Related]
11. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
Musse AA; Harauz G
Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
[TBL] [Abstract][Full Text] [Related]
12. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
13. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions.
Itoyama Y; Webster HD; Richardson EP; Trapp BD
Ann Neurol; 1983 Sep; 14(3):339-46. PubMed ID: 6195956
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE).
Webster HD; Shii H; Lassmann H
Acta Neuropathol; 1985; 65(3-4):177-89. PubMed ID: 2579517
[TBL] [Abstract][Full Text] [Related]
15. Myelin proteolipid protein, basic protein, the small isoform of myelin-associated glycoprotein, and p42MAPK are associated in the Triton X-100 extract of central nervous system myelin.
Arvanitis DN; Yang W; Boggs JM
J Neurosci Res; 2002 Oct; 70(1):8-23. PubMed ID: 12237860
[TBL] [Abstract][Full Text] [Related]
16. Myelin-associated glycoprotein in demyelinating disorders.
Quarles RH
Crit Rev Neurobiol; 1989; 5(1):1-28. PubMed ID: 2475262
[TBL] [Abstract][Full Text] [Related]
17. Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.
Sato S; Quarles RH; Brady RO; Tourtellotte WW
Ann Neurol; 1984 Mar; 15(3):264-7. PubMed ID: 6202231
[TBL] [Abstract][Full Text] [Related]
18. Imaging evaluation of demyelinating processes of the central nervous system.
Smith AB; Smirniotopoulos JG
Postgrad Med J; 2010 Apr; 86(1014):218-29. PubMed ID: 20354045
[TBL] [Abstract][Full Text] [Related]
19. Determination of the sequential degradation of myelin proteins by macrophages.
van der Goes A; Boorsma W; Hoekstra K; Montagne L; de Groot CJ; Dijkstra CD
J Neuroimmunol; 2005 Apr; 161(1-2):12-20. PubMed ID: 15748939
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes.
Banik NL
Crit Rev Neurobiol; 1992; 6(4):257-71. PubMed ID: 1384994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
